This article is more than 5 years old. Information may no longer be current.
Allergan reports 14.6% growth in net product sales for fourth quarter
Allergan reported $1.66 billion in total product net sales for the fourth quarter, which constitutes a 14.6% increase over total product net sales for the corresponding quarter in 2012, according to a press release.
Total specialty pharmaceuticals net sales increased 14% compared with the fourth quarter of 2012, and total core medical devices net sales increased 17% over the prior year’s fourth-quarter numbers.
Allergan also reported $1.04 in diluted earnings per share attributable to stockholders, which is less than the $1.05 in diluted earnings per share attributable to stockholders reported for the fourth quarter of 2012.
Non-GAAP diluted earnings per share attributable to stockholders was $1.35 for the fourth quarter, compared with $1.12 reported for the fourth quarter a year ago, a 20.5% increase.